Skip to main content

Diagnostic Imaging Market: Exploring the Impact of Telemedicine on 5-6% CAGR Leading into 2029

 

The global diagnostic imaging market is expected to witness a growth rate of 5-6% during the forecast period. This growth is driven by the increasing incidences of chronic diseases, the rising demand for diagnostic imaging services, the growing awareness about preventive healthcare, and technological advancements associated with diagnostic imaging services.

Diagnostic imaging encompasses various techniques healthcare professionals employ to visually inspect and analyze the body's internal structures for medical purposes. These imaging modalities play a crucial role in diagnosing and monitoring various diseases and conditions, offering vital information that aids surgeons and healthcare professionals in comprehending the size, location, and extent of tumours or abnormalities. This information enhances surgical precision and facilitates the implementation of targeted therapies, showcasing the significance of diagnostic imaging in patient care, medical research, and healthcare systems. Key modalities and techniques include X-ray imaging, a traditional method utilizing ionizing radiation; Computed Tomography (CT), which provides 3D imaging through X-rays; Magnetic Resonance Imaging (MRI), utilizing strong magnetic fields and radio waves; Ultrasound, employing sound waves to generate images; and Nuclear Medicine, involving the use of radioactive tracers for imaging.

Download a free sample report now 👉

https://meditechinsights.com/diagnostic-imaging-market/request-sample/

Technological Advances and Healthcare Trends Fueling the Diagnostic Imaging Market

The growth of the diagnostic imaging market is propelled by various factors. Technological advancements play a pivotal role, as ongoing improvements in imaging technologies continually enhance diagnostic accuracy and efficiency. These advancements are giving rise to the production of high-resolution imaging devices that deliver superior image quality and facilitate detailed analysis. An illustrative example is the progress in MRI technology, leading to the creation of high-field MRI systems. These systems offer clearer and more detailed images, enhancing accuracy in diagnoses. For instance,

  • In November 2023, Philips unveiled AI-enabled advancements during the RSNA23 medical imaging conference. These innovations encompass next-generation ultrasound systems designed to boost diagnostic imaging and workflow efficiency, the world's first mobile MRI system operating without helium, and novel AI-enabled cloud solutions aimed at augmenting radiology efficiency

The rising incidence of diseases, particularly chronic conditions, significantly contributes to the increasing demand for diagnostic imaging services. Moreover, the aging population worldwide is a key driver, as the elderly demographic requires more diagnostic procedures, contributing to market expansion. Increased awareness about preventive healthcare practices also encourages early diagnosis through imaging, further fueling the demand for diagnostic imaging services. Together, these factors form a dynamic landscape that supports the continuous growth of the diagnostic imaging market.

Future-Forward: AI, 3D Printing, and Point-of-Care Imaging Reshape Diagnostic Imaging Services

Recent developments and advancements in diagnostic imaging have significantly transformed the field, enhancing capabilities and patient care. The integration of AI is a notable trend, as AI algorithms enable more accurate image analysis and interpretation, aiding healthcare professionals in diagnosis and treatment planning. For instance,

  • In January 2024, Philips unveiled its AI-powered enterprise imaging solutions, including the Compact Ultrasound System 5000 series and the BlueSeal magnet MRI, at the IRIA 2024, highlighting innovations in ultrasound, MRI, and CT systems
  • In November 2023, Siemens Healthineers launched the Acuson Maple Workhorse Ultrasound System, an advanced, adaptable, and cost-effective ultrasound platform designed to facilitate swift diagnosis and evaluation across diverse clinical environments. The system incorporates artificial intelligence (AI)-driven features, enhancing routine clinical operations for users with varying skill levels

Hybrid imaging, which involves combining different imaging modalities, has become increasingly prevalent. Techniques like PET-CT and SPECT-CT provide more comprehensive diagnostic information by merging the strengths of multiple imaging technologies. This integration aids in more accurate localization and characterization of abnormalities. The advent of 3D printing technology has brought about innovative applications in diagnostic imaging. Clinicians can now create physical models from imaging data, facilitating pre-surgical planning and providing a tangible representation of anatomical structures. This development is particularly valuable in complex surgeries where a precise understanding of the patient's anatomy is crucial. Portable and point-of-care imaging devices represent another significant advancement. Compact and portable imaging tools allow for on-the-spot diagnostic imaging, reducing the need for patients to travel to imaging centres. This is especially beneficial in emergencies or remote healthcare settings where immediate diagnostic information is essential. For instance,

  • In August 2023, GE HealthCare launched the Vscan Air SL, a wireless handheld ultrasound device with a dual-headed probe featuring sector and linear arrays, enabling seamless cardiac and vascular assessments at the point of care, both in and out of hospital settings
  • In February 2022, FUJIFILM Sonosite, Inc. expanded its next-generation point-of-care ultrasound (POCUS) offerings with the introduction of the Sonosite LX system. This system incorporates the company's most extensive clinical image and a monitor with extended, rotating, and tilting capabilities, facilitating improved real-time collaboration for healthcare providers

Diagnostic Imaging Market: Key Constraints/Challenges

The challenges in diagnostic imaging include substantial initial and maintenance costs for advanced equipment, posing financial barriers for healthcare facilities. Concerns about radiation exposure in modalities using ionizing radiation and challenges related to reimbursement policies and healthcare financing further complicate the landscape.

North America Accounts for the Largest Share of the Global Market

The size of the market varies across regions, with typically more well-established services in developed countries. North America dominates the global market owing to its robust research and development efforts and advanced healthcare system featuring medical facilities equipped with advanced diagnostic imaging devices. The region's emphasis on medical research and clinical trials further drives the demand for diagnostic imaging. Additionally, favourable insurance and reimbursement policies, especially in the US contribute to increased accessibility and affordability of diagnostic imaging services for patients, thereby propelling market growth. Meanwhile, the Asia-Pacific region is experiencing rapid expansion in the forecast period. Countries in this region have been investing in healthcare infrastructure and adopting modern diagnostic imaging equipment to meet the rising demand for diagnostic imaging services.

Competitive Landscape

The global diagnostic imaging market is marked by the presence of established and emerging market players such as GE Healthcare; Koninklijke Philips N.V.; Siemens Healthineers; Canon Medical Systems Corporation; Mindray Medical International; FUJIFILM VisualSonics Inc.; Carestream Health; Hitachi; Samsung Medison Co., Ltd.; PerkinElmer Inc.; Hologic, Inc.; and Varex Imaging among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, and acquisitions to garner market share. For instance,

  • In October 2024, Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation Japan, acquired California X-ray Imaging Services, Inc. to enhance its healthcare business expansion in North America
  • In October 2023, Carestream Health revealed its collaboration with EXAMION to introduce innovative, Future-Focused Healthcare Imaging Solutions to Germany. Through this alliance, Carestream strives to enhance patient experience, and clinical outcomes, and streamline radiography workflows by delivering diagnostic imaging solutions to healthcare organizations in Germany and other European countries
  • In November 2022, Siemens Healthineers inaugurated its Ultrasound manufacturing facility in Košice, Slovakia, marking its first establishment in Europe. The facility boasts an initial production capacity of up to 120 systems per week and will serve as a strategic expansion of the company's manufacturing capabilities for ultrasound products

The diagnostic imaging market continues to evolve with ongoing research, technological innovations, an increasing focus on personalized and precise medical diagnostics and aggressive organic and inorganic growth strategies followed by the players.

Download a sample report for in-depth competitive insights

https://meditechinsights.com/diagnostic-imaging-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global diagnostic imaging market at the regional- and country-level from 2022 to 2029. The report further segments the market based on product, application, and end user.

  • Market Size & Forecast (2022-2029), By Product, USD Million
    • CT Scanners
    • Ultrasound Systems
    • X-ray Imaging Systems
    • Nuclear Imaging Systems
    • MRI Systems
    • Mammography Systems
  • Market Size & Forecast (2022-2029), By Application, USD Million
    • X-ray Imaging Systems
      • General Radiography
      • Fluoroscopy
      • Dentistry
    • MRI Systems
      • Brain and Neurological MRI
      • Spine and Musculoskeletal MRI
      • Pelvis and Abdominal MRI
      • Vascular MRI
      • Breast MRI
      • Cardiac MRI
    • CT Scanners
    • Ultrasound Systems
      • Radiology/General Imaging
      • Cardiology
      • Gynecology
      • Urology
      • Other Applications
    • Nuclear Imaging Systems
      • Cardiology
      • Neurology
      • Oncology
      • Other Applications
    • Mammography Systems
  • Market Size & Forecast (2022-2029), By End User, USD Million
    • Hospitals
    • Diagnostic Centers
    • Academic and Research Institutes
    • Others
  • Market Size & Forecast (2022-2029), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more